Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

MDS Curriculum Track: Treatment of Dystonia

Length:8 HoursCME Credits:0Release Date:Jun 11, 2021

Experienced / Intermediate

Program Description

The MDS Curriculum Track “Treatment of Dystonia”  features 8 hours of content comprising 1 presentation, 1 blog, 6 videos, and 4 journal articles presented by global experts. This curriculum provides intermediate-level content that provides the learner with an overview of treatment options.

Topics

  • Hyperkinetic Movement Disorders

Faculty

Features Lectures and Resources By:
Michele Tagliati, MD, Cedars-Sinai Medical Center, Los Angeles, California, USA
Joseph Jankovic, MD, Baylor College of Medicine, Houston, Texas, USA
Alberto Albanese MD - University Cattolica del Sacro Cuore, Rozzano, Milan, Italy
Cynthia Comella, MD – Rush University, Chicago, Illinois, USA
Travis Tierney, MD, PhD – Brigham and Women’s Hospital, Boston, Massachusetts, USA
Amit Batla, MBBS, MD, DM – University College London, London, United Kingdom
Cecilia Prudente, PT, PhD – University of Minnesota Twin Cities, Minneapolis, Minnesota, USA
Lynley Bradnam, PhD – the University of Auckland, Auckland, New Zealand
Teresa Kimberly, PhD, Massachusetts General Hospital, Boston, Massachusetts, USA

Content Edited By: Brian Berman, MD - Virginia Commonwealth University, Richmond, Virginia, USA

Content Curated By: Amal Abu Libdeh, Amanda Persaud, Mariana H.G.Monje, Chauncey Spears, Molly Cincotta, Sandy Cartella

Course Purpose

The primary purpose of the program is to provide experienced learners with concepts related to treatment options available for dystonia including non-pharmacological, pharmacologic, and surgical interventions.

Learning Objectives

At the completion of this curriculum track, participants will be able to: 
1. Describe the rehabilitative and non-pharmacological therapeutic approaches to treating dystonia.
2. Evaluate the pharmacologic treatment options available for dystonia including chemo-denervation approaches.
3. Summarize the variety of surgical approaches available to treat dystonia and their indications for use.
 

Intended Audience

The activity is intended for students, residents, neurologists, neurosurgeons, specialist nurses, and health professionals.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Mozilla Firefox or Google Chrome.
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker

Contact Us

MDS Education

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice